NINDS Advisory Council Agenda - February 1, 2018

NINDS Advisory Council Agenda - February 1, 2018


National Institutes of Health

National Institute of Neurological Disorders and Stroke


National Advisory Neurological Disorders and Stroke Council

201st Meeting

February 1, 2018

Neuroscience Center (NSC) Building, Conference Room C/D
6001 Executive Boulevard
Rockville, Maryland 20852

NIH Videocast Website:



February 1, 2018



8:00 a.m.

I.  Call to Order and Opening Remarks
     Dr. Walter Koroshetz, Chairperson, Director, NINDS

8:05 a.m.

II.  Report of the Director, Division of Extramural Activities, NINDS
      Dr. Robert Finkelstein, Executive Secretary, NANDS Council

  1. Consideration of Minutes of September 7, 2017, Meeting
  2. Confirmation of Dates for Future Council Meetings        

                                                Thursday, May 24, 2018    

                                                Thursday, September 13, 2018

                                                Thursday, February 14, 2019   

                                                Thursday, May 23, 2019                 

                                                Thursday, September 5, 2019

      C.     Other Items

                           Council Operating Procedures

                           Expedited Review Process

                           Extramural Announcements

8:15 a.m.

III.  Report of the Director, NINDS
       Dr. Walter Koroshetz

9:15 a.m.

IV.  Institutional Translational Research Training Programs (T32)
       Dr. Amir Tamiz, Division of Translational Research
       Dr. Stephen Korn, Office of Training and Workforce Development

9:45 a.m.

V.  Promoting Opportunities for Women and Under-Represented groups in Neuroscience through New Faculty Hiring
     Dr. Stephen Korn, Office of Training and Workforce Development
     Dr. Michelle Jones-London, Office of Programs to Enhance Neuroscience Workforce Diversity

10:15 a.m.


10:30 a.m.

VI.  NIH Director’s Perspective
       Dr. Francis Collins, Director, National Institutes of Health

11:00 a.m.

VII.  Proposed Special Council Review (SCR) Process
         Dr. Robert Finkelstein, Director, Division of Extramural Activities

11:30 a.m.


12:45 p.m.

VIII. Initiatives Requiring Concept Clearance:

A Clinical Trials Network for Pain
Dr. Linda Porter, Office of Pain Policy

Biomarkers to Accelerate the Development of Non-Addictive Pain Medications
Dr. Linda Porter, Office of Pain Policy

Stroke Preclinical Assessment Network (SPAN)
Dr. Francesca Bosetti
Neural Environment Cluster

1:45 p.m.


2:00 p.m.


This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

IX.  Review of Conflict of Interest, Confidentiality, and Council Procedures
       Council Consideration of Pending Applications  
       Dr. Robert Finkelstein 

5:00 p.m. **